Treating Heart Failure With Enhanced External Counterpulsation (EECP)

Charite University, Berlin, Germany

Overview

Enhanced external counterpulsation (EECP) is an outpatient coronary artery disease (CAD) therapy that involves the cyclical inflation/deflation of cuffs wrapped around the lower extremities. However, the possible benefits of EECP in patients with heart failure (HF) (New York Heart Association \[NYHA\] classes II to IV) and cardiomyopathy are unclear.

Study Type

OBSERVATIONAL

Conditions

Heart Failure

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with heart failure (NYHA II-IV) 1. with optimal medical therapy 2. caused by ischemic or non-ischemic cardiomyopathy * EECP-Therapy and Treatment in the Cardio Centrum Berlin or Charité - University Medicine Berlin * Aged 18 to 100 years * Offered patient information and written informed consent Exclusion Criteria: * Participation in another interventional trial * Acute coronary syndrome \< 4 weeks prior to enrollment * Operation \< 4 weeks prior to enrollment * Stroke \< 4 weeks prior to enrollment * Clinically significant disease with hospitalization * Aortic valvular heart disease ≥ moderate * Aortic aneurysm * clinically relevant severe cardiopulmonal diseases * Resting RR \> 160/90mmHg * Thrombose, Thrombophlebitis \< 8 weeks prior to enrollment * Peripheral artery occlusive disease ≥ Stadium II * Acute Heart failure * Pathological bleeding tendency * Arrhythmias, which interfere with Triggering of the EECP * Other diseases, that inhibit EECP-Treatment (e.g. Spinal disc herniation) * Accommodation in an institution due to an official or judicial order * Women: pregnancy or lactation

Locations (1)

Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charité - University Medicine Berlin

Berlin, Germany